Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,21144,129,1.41 [1.09-1.81],0.0083891731667579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTA2,"Actin, aortic smooth muscle",21144,129,1.47 [1.11-1.94],0.0067062121042977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN2,Alpha-actinin-2,18209,92,1.48 [1.12-1.96],0.0061806639597827
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,21332,132,2.08 [1.21-3.58],0.0083492145384217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,18852,99,2.08 [1.27-3.41],0.0035452771441175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,18873,98,1.56 [1.18-2.05],0.001725668055794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,21724,133,2.47 [1.36-4.48],0.0029880731066873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,21644,130,1.74 [1.19-2.54],0.0041444365268007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBP,Protein AMBP,21690,133,2.77 [1.35-5.68],0.0052980589504428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,21724,133,2.25 [1.57-3.22],8.88511116608786e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,21255,128,2.44 [1.43-4.17],0.0010304236797313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,21610,130,2.00 [1.42-2.82],8.09892287236508e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA2,Annexin A2,18095,94,1.38 [1.10-1.72],0.0053028846607885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,21446,131,1.83 [1.35-2.49],0.0001160088179364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",21644,130,2.28 [1.34-3.88],0.0023534668460961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCHE,Cholinesterase,18516,96,0.50 [0.31-0.81],0.0050075263324241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7B,B-cell CLL/lymphoma 7 protein family member B,18757,97,0.47 [0.27-0.83],0.00912569729568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSG,Basigin,21736,131,2.98 [1.47-6.05],0.0025158314762113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,21668,131,2.87 [1.51-5.45],0.0012850694938907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,18398,97,3.71 [2.09-6.58],7.626293858884979e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA12,Carbonic anhydrase 12,21446,131,1.98 [1.28-3.07],0.0022931884020044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB1,Calbindin,21446,131,1.66 [1.19-2.31],0.0028200397332634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,21557,132,2.04 [1.42-2.92],0.0001065731786827
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL14,C-C motif chemokine 14,21526,132,1.60 [1.16-2.19],0.0036760730358458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,21644,130,1.47 [1.11-1.93],0.0066909683558622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL23,C-C motif chemokine 23,21644,130,1.77 [1.24-2.54],0.0016797063213594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,21768,132,1.57 [1.15-2.15],0.0048455947740274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN3,CCN family member 3,21786,134,1.82 [1.22-2.71],0.0035561194553182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN5,CCN family member 5,21578,131,1.85 [1.25-2.72],0.0019578512268222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD27,CD27 antigen,21637,130,1.64 [1.18-2.29],0.0032948773618679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD274,Programmed cell death 1 ligand 1,21365,132,1.72 [1.16-2.53],0.0067214020809009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,21549,130,2.61 [1.69-4.03],1.5304585871564e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,21446,131,2.15 [1.40-3.32],0.0004894008978987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD74,HLA class II histocompatibility antigen gamma chain,21734,134,1.76 [1.16-2.67],0.0074831850658636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,21768,132,1.50 [1.11-2.02],0.0084984604648995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99,CD99 antigen,21578,131,2.66 [1.30-5.45],0.0076245857109063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH6,Cadherin-6,21557,132,1.67 [1.14-2.45],0.0080943357377836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,21144,129,1.53 [1.15-2.02],0.003288164742897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",18809,98,2.03 [1.37-3.00],0.0003938290378859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,21131,129,1.30 [1.09-1.54],0.0028704029308158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL1,Chordin-like protein 1,21610,130,2.19 [1.37-3.48],0.0009836688082975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CINP,Cyclin-dependent kinase 2-interacting protein,18501,97,0.43 [0.24-0.77],0.0043282440755373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,21674,131,2.28 [1.52-3.42],6.118263444037152e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,18852,99,1.68 [1.22-2.31],0.0014879417735679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,21495,132,1.94 [1.19-3.14],0.0074497824474115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,21724,133,2.71 [1.44-5.11],0.0021009667732187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,21768,132,2.18 [1.63-2.93],1.9848293357207746e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,21667,133,3.92 [2.13-7.23],1.1825390975299397e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,21557,132,2.09 [1.47-2.98],4.005678747298759e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,21821,134,2.16 [1.51-3.09],2.819567932499156e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,21549,130,2.33 [1.39-3.92],0.0013652071972806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,18213,94,1.84 [1.23-2.76],0.0031006191405184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM2,Inactive carboxypeptidase-like protein X2,18843,97,2.18 [1.32-3.61],0.0024390320137065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIM1,Cysteine-rich motor neuron 1 protein,21644,130,2.73 [1.32-5.64],0.0067492714573531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIP2,Cysteine-rich protein 2,21365,132,1.68 [1.27-2.23],0.0003017630819965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,21644,130,2.65 [1.57-4.47],0.0002747777960278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,18209,92,1.32 [1.12-1.54],0.000606110302237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,21638,132,2.00 [1.25-3.21],0.0039026683825872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,21581,130,1.24 [1.10-1.40],0.0006118304789436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSTB,Cystatin-B,21269,131,1.89 [1.36-2.63],0.0001418470152379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,21604,134,1.51 [1.16-1.96],0.0022102176989701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,16851,104,3.09 [1.47-6.48],0.0028104689415726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,21793,134,2.45 [1.31-4.58],0.0051605692076659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL9,C-X-C motif chemokine 9,21644,130,1.36 [1.10-1.67],0.0040995408070819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,21734,134,2.72 [1.48-5.00],0.0013048597717636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,18213,94,1.37 [1.11-1.70],0.0036014358985208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,21637,130,2.11 [1.32-3.37],0.0017200562135048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,21821,134,4.27 [2.20-8.27],1.7130347181842906e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,21356,130,1.78 [1.18-2.67],0.005514938787004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,18713,97,2.21 [1.51-3.23],4.188763912546517e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,21446,131,2.90 [1.83-4.62],6.508802652309494e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBI3_IL27,Interleukin-27,21686,133,1.94 [1.20-3.14],0.0067106099494411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,21724,133,2.42 [1.74-3.38],1.9423965800312095e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,18378,94,2.72 [1.44-5.13],0.0019755956606514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,21643,132,1.92 [1.21-3.04],0.0056456662975602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,21546,130,1.96 [1.22-3.15],0.0054250998049739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,21332,132,1.85 [1.22-2.80],0.0036173655667752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,18843,97,2.07 [1.22-3.50],0.0066665149769098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,21136,129,1.69 [1.28-2.22],0.0001880008687587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,20772,123,2.13 [1.51-3.00],1.814183566847923e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,21821,134,2.35 [1.38-4.01],0.0017129108646203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,21332,132,1.89 [1.21-2.95],0.0052192372202689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPN1,Epsin-1,18501,97,0.39 [0.21-0.73],0.0034844478199688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",18843,97,1.80 [1.32-2.46],0.0001892407865095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",21821,134,1.71 [1.31-2.23],8.166282131453974e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,21515,132,2.32 [1.45-3.71],0.0004360455435313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX1,"Adrenodoxin, mitochondrial",18209,92,1.40 [1.12-1.76],0.0036932626175358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,21693,133,1.46 [1.18-1.81],0.0004971366459692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,21410,131,2.48 [1.59-3.86],6.281184152847503e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,21514,130,2.59 [1.72-3.90],4.706042973660358e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAP,Gamma-aminobutyric acid receptor-associated protein,18757,97,1.56 [1.17-2.08],0.0024562994398394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,21821,134,2.27 [1.80-2.86],3.48596645004276e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,21015,126,2.10 [1.58-2.80],3.356705775165527e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,21686,133,3.61 [2.32-5.64],1.5115824551752323e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,20875,129,1.24 [1.05-1.47],0.0099622537126165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,21690,133,1.49 [1.20-1.84],0.0003034319376134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,21768,132,2.24 [1.52-3.30],4.599923132650145e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,21724,133,2.46 [1.76-3.44],1.2326463809405226e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR1,Interferon gamma receptor 1,21644,130,2.39 [1.27-4.49],0.0067111187273121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,21795,134,1.75 [1.36-2.26],1.6620665710772542e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,21301,129,1.92 [1.47-2.52],2.081775008426969e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,21821,134,2.07 [1.51-2.84],6.003997649063742e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,21557,132,1.88 [1.25-2.83],0.0025530490443446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,18835,98,1.91 [1.30-2.82],0.0010960756799712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,21505,131,1.94 [1.27-2.97],0.0023565827622075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL19,Interleukin-19,21011,129,1.29 [1.06-1.57],0.0098753658425573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,21037,128,1.38 [1.09-1.74],0.0069243525571985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,21546,130,2.98 [1.62-5.48],0.0004594783901599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,21510,130,1.45 [1.13-1.85],0.003200684129691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36G,Interleukin-36 gamma,18207,95,1.36 [1.11-1.66],0.0032291288294141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,21505,131,1.73 [1.19-2.52],0.0044796275475813
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,21505,131,1.44 [1.12-1.86],0.0049315573439792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,21446,131,1.25 [1.07-1.46],0.0052973734657208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,21671,132,2.01 [1.33-3.02],0.0008170984117922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM2,Junctional adhesion molecule B,21734,134,2.11 [1.28-3.46],0.0032484033228758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,21724,133,1.41 [1.14-1.74],0.0014375002316074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,21549,130,1.69 [1.22-2.33],0.0013780342006126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAYN,Layilin,21332,132,1.75 [1.19-2.57],0.0040593425599066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LECT2,Leukocyte cell-derived chemotaxin-2,18843,97,1.45 [1.10-1.92],0.0094787835160973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS1,Galectin-1,21557,132,1.73 [1.15-2.61],0.0082127933369514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,21457,132,1.56 [1.18-2.07],0.001643695586872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,18806,96,2.33 [1.64-3.31],2.3697645658697807e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP11,Low-density lipoprotein receptor-related protein 11,21557,132,1.91 [1.29-2.84],0.0012419743187755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,18334,92,1.66 [1.23-2.25],0.0009613350805506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,21821,134,2.58 [1.68-3.98],1.676481964602369e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,21457,130,2.05 [1.27-3.29],0.0030629461205501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY6D,Lymphocyte antigen 6D,21446,129,1.65 [1.17-2.31],0.0041514818879468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGEA3,Melanoma-associated antigen 3,18501,97,0.80 [0.68-0.94],0.0060924302854672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,21582,130,2.57 [1.53-4.30],0.0003492315063916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MB,Myoglobin,21821,134,1.43 [1.11-1.84],0.0053356774401376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDK,Midkine,21583,130,1.48 [1.19-1.85],0.0004141308435581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,21108,129,1.74 [1.25-2.42],0.0009078819381806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,21693,134,1.35 [1.12-1.64],0.0019909858476154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,21541,131,1.40 [1.09-1.81],0.0096320815806207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC1,"Myosin-binding protein C, slow-type",18843,97,1.40 [1.10-1.77],0.0061135498494027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,21637,130,2.43 [1.43-4.11],0.0009670661789587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,21724,133,2.69 [1.62-4.49],0.000140727970612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN2,Nectin-2,21515,132,1.96 [1.23-3.11],0.0043834198732637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,20993,130,1.70 [1.25-2.30],0.0006346161205547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS1,"Nitric oxide synthase, brain",21055,131,1.44 [1.10-1.88],0.0077507512881446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,21557,132,2.17 [1.50-3.12],3.201582976030288e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,21144,129,1.23 [1.11-1.38],0.0001666954850348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP1,Neuropilin-1,21700,132,2.14 [1.26-3.64],0.0048092865047979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,18809,98,2.16 [1.57-2.98],2.638838097025606e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,21557,132,1.27 [1.13-1.43],4.982021279051946e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OCLN,Occludin,18806,96,1.72 [1.18-2.50],0.004524287275311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,21578,131,1.66 [1.19-2.31],0.0026349680701692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,21446,131,0.72 [0.58-0.91],0.005775868817831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,21413,131,1.35 [1.08-1.67],0.0070795320451065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,18809,98,2.37 [1.57-3.57],3.9036690506922e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEPD,Xaa-Pro dipeptidase,18856,97,0.36 [0.17-0.74],0.0051338110838097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,21768,132,2.24 [1.36-3.69],0.0016347582257059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,21365,132,2.41 [1.47-3.93],0.0004537107570236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,21307,132,1.58 [1.26-1.99],7.521828672168118e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,21290,129,2.01 [1.34-3.02],0.0007256294471639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,21578,131,1.96 [1.23-3.13],0.004955932764528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,21418,130,3.69 [2.31-5.91],5.1337445420734544e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLG,Plasminogen,18406,97,3.19 [1.64-6.22],0.0006604605992685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,21549,130,2.55 [1.35-4.82],0.0040255452218764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROK1,Prokineticin-1,21505,131,1.47 [1.13-1.92],0.0039441837997647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,21734,134,2.24 [1.56-3.22],1.2724939967941733e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,21612,133,2.72 [1.67-4.45],6.239190366209972e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,18512,96,1.51 [1.17-1.93],0.0012636199453494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANGAP1,Ran GTPase-activating protein 1,21052,127,0.54 [0.36-0.82],0.0034841540875303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,18806,96,2.06 [1.53-2.78],1.96817036501833e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,21429,130,1.45 [1.11-1.90],0.0062900731670038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,21821,134,1.38 [1.09-1.74],0.0073943360131173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,21821,134,1.38 [1.12-1.70],0.0029930547758111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,21582,130,1.89 [1.46-2.45],1.759007436606352e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,21578,131,1.85 [1.16-2.95],0.0098303564564342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REN,Renin,21557,132,1.27 [1.08-1.50],0.0034249843329881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,21524,132,1.58 [1.15-2.17],0.0051979585998337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,21736,133,2.18 [1.37-3.45],0.0009467407166955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO1,R-spondin-1,21365,132,1.74 [1.16-2.60],0.0074432692233178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,21724,133,2.82 [1.86-4.28],1.0880138892446838e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4R,Reticulon-4 receptor,21724,133,1.72 [1.14-2.59],0.0091124735758972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,21388,132,1.41 [1.10-1.80],0.0071794864934797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,20959,131,1.93 [1.30-2.87],0.0012149888255796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,21734,134,2.53 [1.57-4.09],0.0001359143001829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4C,Semaphorin-4C,21446,131,1.73 [1.17-2.54],0.0054702301510892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,21821,134,1.95 [1.33-2.85],0.0005960698103718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,21302,132,1.90 [1.44-2.50],5.023002405314703e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF8,SLAM family member 8,21052,127,1.51 [1.12-2.03],0.0062227885785211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,21724,133,1.98 [1.30-3.01],0.0015563404356323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC2,SPARC-related modular calcium-binding protein 2,21644,130,1.67 [1.14-2.45],0.0083532370872517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,21365,132,1.67 [1.32-2.11],1.638271334815084e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,21578,131,1.85 [1.38-2.49],4.450361915771212e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,21582,130,2.36 [1.77-3.14],4.8722722429186255e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON2,Spondin-2,21452,131,1.88 [1.23-2.87],0.0037285523984859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACSTD2,Tumor-associated calcium signal transducer 2,19036,114,1.86 [1.27-2.74],0.001502747584509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAFA5,Chemokine-like protein TAFA-5,21446,131,1.76 [1.21-2.58],0.003271564622769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF1,Trefoil factor 1,21471,130,1.28 [1.09-1.52],0.0035386321310694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,21610,130,1.59 [1.26-2.02],0.0001263969812629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,21553,132,1.58 [1.23-2.02],0.0003777631175548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,21637,130,1.76 [1.20-2.58],0.003604987210791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,21578,131,1.68 [1.18-2.40],0.0040765014098812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP1,Metalloproteinase inhibitor 1,21353,131,1.99 [1.23-3.22],0.0053575881982391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMSB10,Thymosin beta-10,21578,131,1.34 [1.09-1.65],0.0055538580457793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,21365,132,1.74 [1.25-2.43],0.0011270143954253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,21365,132,1.36 [1.12-1.66],0.0022607445900478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,21768,132,1.60 [1.12-2.28],0.0089691297809125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,21549,130,3.13 [1.97-4.96],1.2704449741470276e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,21637,130,1.76 [1.18-2.63],0.0054374881191384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,21582,130,1.84 [1.39-2.43],1.6392490943957266e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,21582,130,1.98 [1.26-3.11],0.0030906162376051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,21724,133,2.06 [1.40-3.04],0.0002485639357448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,21578,131,2.17 [1.43-3.31],0.0003023559981863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF10,Tumor necrosis factor ligand superfamily member 10,21768,132,0.43 [0.24-0.78],0.0051697988682742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,18209,92,1.49 [1.19-1.88],0.000642769229538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG2,V-set and immunoglobulin domain-containing protein 2,18757,97,1.50 [1.17-1.93],0.0013199949481844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,20482,122,2.04 [1.49-2.79],7.72561482780702e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,21724,133,2.07 [1.34-3.21],0.0010254282681245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,21730,134,1.94 [1.31-2.87],0.0009761517584009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,18809,98,3.52 [1.96-6.33],2.5828409165836088e-05
